Nuo Therapeutics, Inc. (AURX)

Market Cap	50.56M
Revenue (ttm)	1.17M
Net Income (ttm)	-2.48M
Shares Out	46.82M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	1.080
Previous Close	1.080
Day's Range	1.080 - 1.080
52-Week Range	0.252 - 1.270
Beta	-773.47
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Nuo Therapeutics

Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: AURX

Financial Performance

In 2023, Nuo Therapeutics's revenue was $608,525, an increase of 442.12% compared to the previous year's $112,250. Losses were -$3.17 million, -0.01% less than in 2022.